Quantum BioPharma Ltd. (CSE:QNTM)
Canada · Delayed Price · Currency is CAD 4.850
-0.060 (-1.22%)
At close: Feb 27, 2026
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of CAD 18.6 million as of March 2, 2026. Its market cap has decreased by -42.38% in one year.
Market Cap
18.60M
Enterprise Value
19.06M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.85
Market Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from 158.35M to 18.60M, a decrease of -88.26%. That is a compound annual growth rate of -24.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 18.60M | -53.81% |
| Dec 31, 2025 | 40.26M | 301.84% |
| Dec 31, 2024 | 10.02M | -78.79% |
| Dec 29, 2023 | 47.25M | 18.00% |
| Dec 30, 2022 | 40.04M | -24.98% |
| Dec 31, 2021 | 53.38M | 39.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Devonian Health Group | 33.88M |
| Microbix Biosystems | 33.25M |
| Telescope Innovations | 29.90M |
| Thiogenesis Therapeutics | 29.03M |
| Rapid Dose Therapeutics | 18.25M |
| Hemostemix | 16.60M |
| Britannia Life Sciences | 15.41M |
| Lobe Sciences | 14.82M |